Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices

Ahmed Bahaa; Tamer Elbaz; Hesham Elmakhzangy; Mohammed Shehata; Dalia Abd El-Kareem; AbdelAziz Gaber; Mohamed B. Hashem; Maissa El Raziky

doi:10.1016/j.ajg.2024.07.003

Q2 2024

Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices

Ahmed Bahaa · Tamer Elbaz · Hesham Elmakhzangy · Mohammed Shehata · Dalia Abd El-Kareem · AbdelAziz Gaber · Mohamed B. Hashem · Maissa El Raziky

10.1016/j.ajg.2024.07.003 393 Views 3 Citations

Citations

393

Views

Abstract not available for this publication.

Cite this Article (APA)

Ahmed, B., Tamer, E., Hesham, E., Mohammed, S., Dalia, A. E., AbdelAziz, G., Mohamed, B. H., Maissa, E. R. (2024). Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2024.07.003